Skip to content

Research on a Blood Stasis Syndrome Identification System Based on HemoSpectroscopic Optical Imaging Technology

Research on a Blood Stasis Syndrome Identification System Based on HemoSpectroscopic Optical Imaging Technology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2026000149
Enrollment
Unknown
Registered
2026-01-24
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases

Interventions

Cardiovascular Disease Group (Coronary Heart Disease and/or Hypertension):Not applicable

Sponsors

Ophthalmology Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Participants aged between 18 and 80 years. 2. Participants including patients with coronary heart disease and hypertension, as well as healthy individuals. Patients with coronary heart disease and hypertension must meet the corresponding Western medicine diagnostic criteria; healthy individuals must be confirmed by comprehensive physical examination to be free from cardiovascular diseases and other major illnesses. 3. Voluntary participation in this study with written informed consent provided.

Exclusion criteria

Exclusion criteria: 1. Patients with severe dysfunction of vital organs, such as the liver, kidneys, or lungs. 2. Patients with psychiatric disorders who are unable to cooperate with study-related examinations and assessments. 3. Individuals who have undergone major surgery within the past 3 months, or women who are pregnant or breastfeeding. 4. Individuals with facial skin diseases or injuries that may interfere with the acquisition of hemoglobin spectral optical imaging data. 5. Individuals with long-term residence at high altitude (continuous residence in areas with an altitude above 3,000 meters for more than one year).

Design outcomes

Primary

MeasureTime frame
Disease and Syndrome Diagnosis Indicators;Screening Indicators;Main Diagnostic Efficacy Indicators;

Secondary

MeasureTime frame
Consistency Indicators;Correlation Indicators;

Countries

China

Contacts

Public ContactGaozhuye

Ophthalmology Hospital, China Academy of Chinese Medical Sciences

zhuyegao@126.com13161267976

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 7, 2026